APA (7th ed.) Citation

A, G., A, G., EC, L., TN, Q., K, v. K., J, W., . . . LM, L. (2025). AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy models. Nature communications, 16(1), 2196. https://doi.org/10.1038/s41467-025-57481-7

Chicago Style (17th ed.) Citation

A, Greer-Short, et al. "AAV9-mediated MYBPC3 Gene Therapy with Optimized Expression Cassette Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models." Nature Communications 16, no. 1 (2025): 2196. https://doi.org/10.1038/s41467-025-57481-7.

MLA (9th ed.) Citation

A, Greer-Short, et al. "AAV9-mediated MYBPC3 Gene Therapy with Optimized Expression Cassette Enhances Cardiac Function and Survival in MYBPC3 Cardiomyopathy Models." Nature Communications, vol. 16, no. 1, 2025, p. 2196, https://doi.org/10.1038/s41467-025-57481-7.